scholarly journals Increased Susceptibility to Experimental Autoimmune Neuritis after Upregulation of the Autoreactive T Cell Response to Peripheral Myelin Antigen in Apolipoprotein E-Deficient Mice

2004 ◽  
Vol 63 (2) ◽  
pp. 120-128 ◽  
Author(s):  
Shuo Yu ◽  
Rui-Sheng Duan ◽  
Zhiguo Chen ◽  
Hernan Concha Quezada ◽  
Lei Bao ◽  
...  
2005 ◽  
Vol 24 (1-2) ◽  
pp. 111-122 ◽  
Author(s):  
Mario M. D'Elios ◽  
Amedeo Amedei ◽  
Annalisa Azzurri ◽  
Marisa Benagiano ◽  
Gianfranco Del Prete ◽  
...  

Blood ◽  
2003 ◽  
Vol 101 (2) ◽  
pp. 621-623 ◽  
Author(s):  
Masataka Kuwana ◽  
Yutaka Kawakami ◽  
Yasuo Ikeda

The potential immunosuppressive effect of an anti-CD154 monoclonal antibody (mAb) on the pathogenic autoreactive T-cell response was evaluated using an in vitro culture system with glycoprotein IIb/IIIa (GPIIb/IIIa)–reactive T cells from patients with immune thrombocytopenic purpura (ITP). The anti-CD154 mAb did not inhibit T-cell proliferation, but suppressed anti-GPIIb/IIIa antibody production, in bulk peripheral blood mononuclear cell cultures stimulated with GPIIb/IIIa. Repeated antigenic stimulation of GPIIb/IIIa-reactive CD4+ T-cell lines in the presence of anti-CD154 mAb resulted in the loss of proliferative capacity and helper function for promoting anti-GPIIb/IIIa antibody production. These anergic T-cell lines showed a cytokine profile of low interferon γ and high interleukin 10 and suppressed anti-GPIIb/IIIa antibody production. Our results indicate that blockade of the CD40/CD154 interaction induces generation of autoantigen-specific anergic CD4+ T cells with regulatory function and could be a therapeutic option for suppressing pathogenic autoimmune responses in patients with ITP.


2003 ◽  
Vol 100 (19) ◽  
pp. 10919-10924 ◽  
Author(s):  
D. Ishida ◽  
H. Yang ◽  
K. Masuda ◽  
K. Uesugi ◽  
H. Kawamoto ◽  
...  

2008 ◽  
Vol 180 (9) ◽  
pp. 6193-6198 ◽  
Author(s):  
Hajime Sasaki ◽  
Noriyuki Suzuki ◽  
Ralph Kent ◽  
Nobuyuki Kawashima ◽  
Junji Takeda ◽  
...  

2008 ◽  
Vol 82 (10) ◽  
pp. 4697-4705 ◽  
Author(s):  
Nicolas P. Andrews ◽  
Christopher D. Pack ◽  
Aron E. Lukacher

ABSTRACT The CD8 coreceptor is important for positive selection of major histocompatibility complex I (MHC-I)-restricted thymocytes and in the generation of pathogen-specific T cells. However, the requirement for CD8 in these processes may not be essential. We previously showed that mice lacking β2-microglobulin are highly susceptible to tumors induced by mouse polyoma virus (PyV), but CD8-deficient mice are resistant to these tumors. In this study, we show that CD8-deficient mice also control persistent PyV infection as efficiently as wild-type mice and generate a substantial virus-specific, MHC-I-restricted, T-cell response. Infection with vesicular stomatitis virus (VSV), which is acutely cleared, also recruited antigen-specific, MHC-I-restricted T cells in CD8-deficient mice. Yet, unlike in VSV infection, the antiviral MHC-I-restricted T-cell response to PyV has a prolonged expansion phase, indicating a requirement for persistent infection in driving T-cell inflation in CD8-deficient mice. Finally, we show that the PyV-specific, MHC-I-restricted T cells in CD8-deficient mice, while maintained long term at near-wild-type levels, are short lived in vivo and have extremely narrow T-cell receptor repertoires. These findings provide a possible explanation for the resistance of CD8-deficient mice to PyV-induced tumors and have implications for the maintenance of virus-specific MHC-I-restricted T cells during persistent infection.


Sign in / Sign up

Export Citation Format

Share Document